ATAI Life Sciences Stock Forum

$Kazia Therapeutics(KZIA.US)$
You should check out $ATAI Life Sciences(ATAI.US)$ as well.  😉

$Biodexa Pharmaceuticals(BDRX.US)$
$ATAI Life Sciences(ATAI.US)$  looks good too!  It'll be interesting to see the advancements coming with their medicine.  Especially with John Hopkins University doing similar research.

$Silo Pharma(SILO.US)$
$ATAI Life Sciences(ATAI.US)$  looks good too!  It'll be interesting to see the advancements coming with their medicine.  Especially with John Hopkins University doing similar research.

$Catheter Precision(VTAK.US)$
$ATAI Life Sciences(ATAI.US)$  looks pretty good too!

$ATAI Life Sciences(ATAI.US)$ atai Life Sciences Announces Update on Beckley Psytech's Phase 1/2a Trial of ELE-101 (IV Psilocin) for Major Depressive Disorder, with Initial Results from Phase 1 and First Patients Dosed in Phase 2a
4 MINUTES AGO, 7:00 AM EDT
VIA GLOBENEWSWIRE
• ELE-101 is a patent-protected, synthetic formulation of psilocin, designed to offer the therapeutic benefits of psilocybin in a more consistent, controllable, and shorter treatment paradigm of approximately two hour...

$ATAI Life Sciences(ATAI.US)$
atai Life Sciences Announces Update on Beckley Psytech’s Phase 1/2a Trial of ELE-101 (IV Psilocin) for Major Depressive Disorder, with Initial Results from Phase 1 and First Patients Dosed in Phase 2a
atai Life Sciences has provided an update on Beckley Psytech's Phase 1/2a trial of ELE-101 for Major Depressive Disorder (MDD). ELE-101 is a synthetic psilocin formulation designed for a consistent and shorter treatment duration of approximately two hours. The Phas...

$ATAI Life Sciences(ATAI.US)$ Descending triangle forming on an ancient important key level and positive divergences make us believe in a bullish feeling. The trading volume seems to be significant in these areas, but volume is missing. The Fibonnaci retracement seems to indicate a setback at 1.72, but a possible reversal at $1.42-1.45 could happen to... Anticipation of volatility increase and trading 'Options' suggest that market sentiment is bullish. Will t...

$ATAI Life Sciences(ATAI.US)$ Atai Life Sciences Disclosed Dosing Of First Patient In Part 2 Of Beckley Psytech's Phase 2a Study Exploring BPL-003 Adjunctive To SSRIs In Patients With Treatment Resistant Depression

$ATAI Life Sciences(ATAI.US)$ Gap down from 2.63 to 1.50 has finally been completely filled today! Break upward past 2.85?  And 3.10 with buy side pressure is next lvl

$ATAI Life Sciences(ATAI.US)$ Still a lovely mover!